Study: Covaxin developed by Indian Pharma firm Bharat Biotech neutralizes UK variant | COVID-19

(1:43)

'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy

(9:)

Bharat Biotech case study | Story of Krishna Ella - The founder of Bharat Biotech

(3:47)

'Bharat Biotech Has Links With Former CM Naidu,' Alleges Andhra Pradesh CM Jagan Mohan Reddy

(3:45)

How Will The COVID-19 Nasal Vaccine Work? | Bharat Biotech Nasal Vaccine Gets Govt Approval

(1:27)

PM Modi visits Bharat Biotech facility in Hyderabad

(1:9)

PM Modi Arrives In Hyderabad, To Visit Bharat Biotech Facility To Review COVID19 Vaccine Development

(1:18)

Covid vaccine: Bharat Biotech ends deal with Brazil; EU approves Moderna for kids

(1:48)

Bharat Biotech's Covaxin Shows Promising Results | Coronavirus Vaccine Update

(1:6)

‘Only India can satisfy world’s demand for Covid-19 vaccines’: Australian Envoy

(2:34)

Davos Brainstorm 2025 | India's Economic Blueprint: Manufacturing, Services And AI To Drive Growth

(44:46)

WEF Davos | India's Blueprint For Global Leadership

(46:41)

Bharat Biotech's Chief Krishna Ella In An Exclusive Conversation With Raj Chengappa | India Today

(39:40)

64 foreign envoys arrive at Bharat Biotech in Hyderabad

(1:49)

Bharat Biotech's Nasal Covid Vaccine iNCOVACC Launched By The Centre

(1:21)

Watch: PM Modi's 2nd Covid vaccine lab visit to Bharat Biotech in Hyderabad

(1:42)

Coronavirus Vaccine| Bharat Biotech's Top Brass Slams Covaxin Critics| Covid-19 News | Covid Vaccine

(4:15)

WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy: Bharat Biotech

(38)

India's first indigenous vaccine 'Covaxin' gets expert panel's nod | Bharat Biotech | World News

(1:25)

Suchitra’s Vision Behind setting up Bharat Biotech

(1:33)

Covishield \u0026 Covaxin: This Is What Serum Institute \u0026 Bharat Biotech Will Charge For The Vaccines

(4:50)

Bharat Biotech Founder Suchitra Ella Shares What Made Her Come Back To India \u0026 Serve Bharat

(3:53)

Bharat Biotech's Vaccine Cleared By Panel, Regulator's Approval Awaited

(1:15)